Participant flow

S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer · Source last updated 2015-08-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Patients receive E7389 IV on days 1 and 8 of an every 21-day cycle.

   id

   FG000

   title

   Treatment (E7389 IV)

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         4

      type

      Adverse Event

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Withdrawal by Subject

   3. reasons

      1. group Id

         FG000

         num Subjects

         32

      type

      Lack of Efficacy

   4. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      Death

   5. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      not protocol specified

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         40

      type

      STARTED

   2. achievements

      1. comment

         Treatment is not for a fixed period and continues until discontinuation criterion is met.

         group Id

         FG000

         num Subjects

         0

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         40

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

2 patients are not eligible before assignment.

recruitment Details

From June 2006 to December, 2007 a total of 42 patients were enrolled from SWOG institutions

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice